Chorioallantoic membrane measles: development and clinical evaluation of a new further attenuated measles vaccine
- PMID: 4856949
- PMCID: PMC380131
- DOI: 10.1128/am.27.4.763-766.1974
Chorioallantoic membrane measles: development and clinical evaluation of a new further attenuated measles vaccine
Abstract
A new, further attenuated measles vaccine, developed by propagation of Edmonston B measles virus in the chorioallantoic membrane in ovo, has been clinically evaluated in children and found to compare favorably with a commercially available product. The vaccine is prepared in chick embryo tissue culture and appears to possess noteworthy stability at 4 C.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources